<p>US regulators will confirm in Jul either to approve Qnexa, a initial plumpness drug in some-more than a decade, fluctuating a initial deadline by 3 months, a California-based drug-maker VIVUS said.</p>
<p><img src="http://imageads.googleadservices.com/pagead/ads?format=468x30_aff_img&client=&channel=&output=png&cuid=1341&url=%20http%3A%2F%2Fmedicalinfo.info%2F%3Fp%3D1341" alt="ads?format=468x30_aff_img&client=&channe" /></p>...
0 comments
Post a Comment